期刊文献+

糖尿病大鼠心和肾组织纤维化超微结构的动态观察 被引量:1

ULTRASTRUCTURAL DYNAMIC OBSERVATION OF MYOCARDIAL AND RENAL FIBROSIS IN TYPE 1 DIABETES MELLITUS RATS
原文传递
导出
摘要 目的探讨不同时间点1型糖尿病大鼠模型心、肾组织超微结构的病理变化和特点。方法腹腔注射链尿佐菌素(STZ,65mg/kg)建立SD大鼠1型糖尿病模型,注药后7d造模成功后于4、12、24周心肌、肾脏光镜与电镜观察,并与同龄正常大鼠进行比较。结果与正常对照组比较,电镜发现糖尿病组心肌细胞肌丝稀疏,间质胶原增生;肾组织肾小球毛细血管基底膜弥漫性增厚,间质胶原增生。结论组织纤维化是糖尿病心肌病和糖尿病肾病共同的病理基础,随病程延长而病变加重。 Objective To investigate the myocardial and renal pathomorphology at different stages of type I diabetes mellitus (DM) rats. Methods The diabetes mellitus rat models was induced by a single intraperitoneal injection of Streptozotocin (STZ,Sigma) at a dose of 65mg· kg- 1 body weight. The myocardialand renal pathomorphology changes were observed with light microscope and transmission electron micro- scope at weeks of 4, 12 and 24 after DM was induced. The age- matched normal rats served as control group. Results Compared with control rats, myofilament rarefaction, interstitial collagen hyperplasia in diabetic rats were observed by electron microscope. Diffuse thickening of glomerular capillary basement membrane and interstitial collagen hyperplasia in diabetic rats were observed by electron microscope. Conclusion Tissue fibrosis is the common pathologic basis of diabetic cardiomyopathy and diabetic nephropathy, and the pathological changes increase with the disease course of diabetes mellitus lengthening.
出处 《中国煤炭工业医学杂志》 2015年第5期794-798,共5页 Chinese Journal of Coal Industry Medicine
基金 河北省科技支撑项目(编号:10276105D-48)
关键词 糖尿病大鼠 糖尿病心肌病 糖尿病肾病 纤维化 超微结构 Diabetic rat Diabetic cardiomyopathy Diabetic nephropathy Fibrosis Ultrastructure
  • 相关文献

参考文献9

二级参考文献23

  • 1张路霞,王梅,王海燕.慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2005,21(7):425-428. 被引量:69
  • 2Xue JL,Ma JZ,Louis TA,et al.Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.J Am Soc Nephrol,2001,12:2753-2758.
  • 3Coresh J,Astor BC,Green T,et al.Prevalence of Chronic Kidney Disease and Decreased Kidney Function in the Adult US Population:Third National Health and Nutrition Examination Survey.Am J Kidney Dis,2003,41:1-12.
  • 4Chobanian AV,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on prevention,detection,evaluation and treatment of high blood pressure.JAMA,2003,21:2560-2572.
  • 5Anonymous.KDOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Kidney Disease Outcome Quality Initiative.Am J Kidney Dis,2002,39 Suppl 2:S1-S246.
  • 6Chadban SJ,Briganti EM,Kerr PG,et al.Prevalence of kidney damage in Australian adults:the AusDiab kidney study.J Am Soc Nephrol,2003,14:S131-S138.
  • 7Garg AX,Kiberd BA,Clark WF,et al.Albuminuria and renal insufficiency prevalence guides population screening:results form the NHANESⅢ.Kidney Int,2002,61:2165-2175.
  • 8Ramirez SP,Mcclellan W,Port FK,et al.Risk factors for proteinuria in a large,multiracial,southeast Asian population.J Am Soc Nephrol,2002,13:1907-1917.
  • 9Levey AS,Eckardt KU,Tsukamoto Y,et al.Definition and classification of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO).Kidney Int,2005,67:2089-2100.
  • 10Zuo L,Ma YCH,Wang M,et al.Application of glomerular giltration rate estimating euqtions in Chinese patients with chronic kidney disease.Am J Kidney Dis,2005,45:463-472.

共引文献407

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部